Epocal Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Epocal General Information

Description

Developer of point-of-care blood diagnostic systems designed to improve outcomes and workflow while transforming care delivery across clinical pathways. The company's system offers blood analysis testing at the patient's side on a single room temperature test card, enabling healthcare providers to streamline patient-testing workflow and accelerate clinical decision-making.

Contact Information

Website
www.epoc.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 2060 Walkley Road
  • Ottawa, Ontario K1G 3P5
  • Canada
Primary Industry
Monitoring Equipment
Vertical(s)
Corporate Office
  • 2060 Walkley Road
  • Ottawa, Ontario K1G 3P5
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Epocal Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 12-Jan-2022 Completed Generating Revenue
6. Merger/Acquisition 31-Oct-2017 Completed Generating Revenue
5. Merger/Acquisition 01-Feb-2013 Completed Generating Revenue
4. Later Stage VC (Series C) 10-Apr-2007 Completed Generating Revenue
3. Debt - General 25-Jan-2006 Completed Generating Revenue
2. Early Stage VC (Series B) 07-Apr-2005 $5M $8.2M Completed Generating Revenue
1. Seed Round 19-Nov-2001 $3.2M $3.2M Completed Startup
To view Epocal’s complete valuation and funding history, request access »

Epocal Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of point-of-care blood diagnostic systems designed to improve outcomes and workflow while transforming care de
Monitoring Equipment
Ottawa, Canada

Nehren, Germany
 

Toronto, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Epocal Competitors (4)

One of Epocal’s 4 competitors is Hain Lifescience, a Corporate Backed or Acquired company based in Nehren, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hain Lifescience Corporate Backed or Acquired Nehren, Germany
SQI Diagnostics Corporation Toronto, Canada
QuantuMDx Venture Capital-Backed Newcastle Upon Tyne, United Kingdom
Kypha Venture Capital-Backed Saint Louis, MO
To view Epocal’s complete competitors history, request access »

Epocal Patents

Epocal Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-130757-S Blood analysis system Inactive 26-May-2009
JP-2008501102-A Mixed electrode Active 01-Jun-2004
JP-5060944-B2 Mixed electrode Active 01-Jun-2004
JP-5097182-B2 Diagnostic device incorporating fluid engineering and manufacturing method Active 01-Jun-2004
JP-2010032527-A Diagnostic device incorporating fluidics and method of manufacture Active 01-Jun-2004 G01N27/26
To view Epocal’s complete patent history, request access »

Epocal Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alere Corporation Majority
Covington Capital Corporation Venture Capital Minority
Genesys Capital Venture Capital Minority
Highland Capital Management Hedge Fund Minority
Siemens Healthineers Corporation Majority
To view Epocal’s complete investors history, request access »

Epocal FAQs

  • When was Epocal founded?

    Epocal was founded in 2001.

  • Where is Epocal headquartered?

    Epocal is headquartered in Ottawa, Canada.

  • What industry is Epocal in?

    Epocal’s primary industry is Monitoring Equipment.

  • Is Epocal a private or public company?

    Epocal is a Private company.

  • What is Epocal’s current revenue?

    The current revenue for Epocal is .

  • How much funding has Epocal raised over time?

    Epocal has raised $41.7M.

  • Who are Epocal’s investors?

    Alere, Covington Capital Corporation, Genesys Capital, Highland Capital Management, and Siemens Healthineers have invested in Epocal.

  • Who are Epocal’s competitors?

    Hain Lifescience, SQI Diagnostics, QuantuMDx, and Kypha are competitors of Epocal.

  • When was Epocal acquired?

    Epocal was acquired on 12-Jan-2022.

  • Who acquired Epocal?

    Epocal was acquired by Idexx Laboratories.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »